Menu
SOPHiA GENETICS™ is excited to be a part of the 31st International Precision Med Tri-Con Conference, held in person in San Diego, California from March 26th – 28th.
Stop by booth #124 for a chance to meet our experts, get a sneak peak into the capabilities of the SOPHiA DDM™ Platform and to discover the breadth of our liquid biopsy capabilities.
JLUNCHEON PRESENTATION
Unlocking access to MSK-ACCESS®: A decentralized approach to innovative liquid biopsy technology
Thursday, March 27 | 1:00 -1:30 pm | Liquid Biopsy Track
SOPHiA GENETICS is collaborating with MSK to decentralize MSK-ACCESS® for liquid biopsy. By combining MSK’s clinical expertise in cancer genomics and the predictive algorithms of the SOPHiA DDMTM Platform, we aim to expand access to precision cancer analysis capabilities worldwide. Join our expert speakers to gain insights into the clinical utility of liquid biopsy at MSK and explore the analytical performance data of MSK-ACCESS® powered with SOPHiA DDMTM – a decentralized application.
Speakers:
Rose Brannon, PhD – Director of Clinical Bioinformatics, Memorial Sloan Kettering Cancer Center (MSK)
Chloe Ryder, PhD – Product Manager for Liquid Biopsy, SOPHiA GENETICS
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
